[HTML][HTML] The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
A Visentin, L Bonaldi, GM Rigolin, FR Mauro… - …, 2022 - ncbi.nlm.nih.gov
Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
A Visentin, L Bonaldi, GM Rigolin… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.
A Visentin, L Bonaldi, GM Rigolin, FR Mauro… - …, 2022 - europepmc.org
Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
[PDF][PDF] The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
haematologica, 2022 - core.ac.uk
Chronic lymphocytic leukemia (CLL), the most common leukemia in western countries, is a
remarkably heterogeneous disease, with some patients never requiring treatments and …
remarkably heterogeneous disease, with some patients never requiring treatments and …
The complex karyotype landscape in chronic lymphocytic leukemia allows to refine the risk of Richter syndrome transformation
A Visentin, L Bonaldi, GM Rigolin, FR Mauro… - …, 2022 - sfera.unife.it
Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
[PDF][PDF] The complex karyotype landscape in chronic lymphocytic leukemia allows to refine the risk of Richter syndrome transformation
A Visentin, L Bonaldi, GM Rigolin, FR Mauro… - researchgate.net
Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
[HTML][HTML] The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
A Visentin, L Bonaldi, GM Rigolin, FR Mauro… - …, 2022 - haematologica.org
Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
A Visentin, L Bonaldi, GM Rigolin, FR Mauro… - …, 2022 - research.unipd.it
Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
[PDF][PDF] The complex karyotype landscape in chronic lymphocytic leukemia allows to refine the risk of Richter syndrome transformation
A Visentin, L Bonaldi, GM Rigolin, FR Mauro… - scholar.archive.org
Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK …
[PDF][PDF] The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
haematologica, 2022 - iris.unife.it
Chronic lymphocytic leukemia (CLL), the most common leukemia in western countries, is a
remarkably heterogeneous disease, with some patients never requiring treatments and …
remarkably heterogeneous disease, with some patients never requiring treatments and …